Chersi is an independent director with strong financial expertise (former CFO at Fidelity, CPA background, current audit committee chair), no attendance issues, no overboarding concerns, and AAMI's 3-year price return of +192.4% outpaces the peer group median by +132.5 percentage points — far exceeding the 65-point threshold needed to trigger a negative vote.

Kim is classified as independent by the board, has no attendance issues, holds no other public board seats that would trigger overboarding concerns, and AAMI's strong TSR far exceeds the peer benchmark, so the TSR trigger does not apply.

Paulson serves as Board Chairman with deep financial services experience; while he also serves on two other public company boards (Bausch Health and Bausch + Lomb), this does not exceed the four-board threshold for non-executive directors, and AAMI's outstanding TSR performance — +132.5 percentage points above the peer median over three years — means the TSR trigger does not apply.

Trebbi is an independent director and compensation committee chair with over 30 years of international investment experience, no attendance issues, no overboarding, and AAMI's strong TSR performance means the TSR trigger does not apply.

Young joined the board in January 2025 — fewer than 24 months ago — making her exempt from the TSR underperformance trigger under policy, and her qualifications as a seasoned asset management executive with CFA and CAIA credentials are directly relevant to AAMI's business.